Member Exclusive

New funding for regenerative small molecule development

Scientists from University of Texas Southwestern and Case Western Reserve University have raised US$5.9 million to develop 15-PGDH inhibitors into human therapeutics.

Go to the profile of MedChemNet
Aug 11, 2017

Please sign in or register for FREE to view this content

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...